Award history

Published records by year

Totals include values only when they can be added without obvious duplication. Framework totals and inconsistent values stay on their records but are not added here.

Annual award records and published values included in totals
Year	Awards	Value counted	Values not counted
2024	4	£1,486,849,720	0
2023	2	£417,692,000	0

Supplier relationships

Supplier relationships by value counted

Suppliers are ordered by published value assigned to one supplier, then by award count. Values shared between suppliers or marked as inconsistent are not assigned.

Public buyerNHS England

Published end dates

Contracts with end dates in the next 24 months

1 award.

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024
Supplier: A. Menarini Farmaceutica Internazionale SRL; AMAROX LIMITED; AOP Orphan Ltd; Abbvie Ltd; Accord-UK Ltd; Aguettant Ltd; Alan Pharmaceuticals; Alliance Pharmaceuticals Ltd; Amgen Ltd; Aspen Pharmacare UK Limited; Aspire Pharma Ltd; AstraZeneca; Aventis Pharma ltd t/a Sanofi; B. Braun Medical Limited; Bausch + Lomb (Pharma); Bayer Plc; Biofrontera Pharma GmbH; Biovantic Pharma Limited; Brancaster Pharma Ltd; CLINIGEN HEALTHCARE LIMITED; CST PHARMA LIMITED; Cenote Pharma Limited; Chiesi Limited; Cipla (EU) Limited; Colonis Pharma Ltd; Crescent Pharma Limited; Day Lewis Medical Ltd; Dexcel Pharma Ltd; Dr Falk Pharma UK Ltd; Drugsrus Ltd; ELI LILLY & COMPANY LTD; Ennogen Healthcare Ltd; Essential Pharma; Esteve Pharmaceuticals Limited; Evolan Pharma; FONTUS HEALTH LTD; Ferndale Pharmaceuticals Ltd; Ferring Pharmaceuticals Limited; Flexipharm Austrading Ltd; Flynn Pharma Ltd; Focus Pharmaceuticals Limited; Fresenius Kabi Limited; GLENMARK PHARMACEUTICALS EUROPE LIMITED; GlaxoSmithKline UK Limited; Janssen-Cilag Ltd; Kyowa Kirin Ltd; Lupin Healthcare (UK) Limited; Luye Pharma Ltd; MERCURY PHARMACEUTICALS LIMITED; Martindale Pharma; Merck Serono; Merck Sharpe & Dohme (UK) Limited; Morningside Pharmaeuticals; Napp Pharmaceuticals Ltd; Necessity Supplies Limited; Neon Healthcare; Novartis Pharmaceuticals UK Ltd; Novo Nordisk; ORPHALAN UK LTD; Organon Pharmaceuticals UK Ltd; PARI; Pfizer Ltd; Pharmacosmos UK Ltd; ROSEMONT PHARMACEUTICALS LTD; RPH Pharmaceuticals AB; Reckitt Benckiser; Recordati Rare Diseases UK Ltd; Roche Products Ltd; SERB SA; STIRLING ANGLIAN PHARMACEUTICALS LIMITED; Sandoz Ltd; Selective Supplies Limited; Simple Pharma; Sun Pharma UK Ltd; THEA PHARMACEUTICALS LIMITED; TILLOMED LABORATORIES LIMITED; Takeda UK Ltd; Tetris Pharma Lts; Teva UK Limited; Thornton and Ross Ltd; Tillotts Pharma UK Ltd; Typharm; Uni Health Distribution Ltd; Univar Solutions; Valneva UK Ltd; Venture Healthcare Ltd; Waymade PLC; Wockhardt UK Limited; Xiromed; ZENTIVA PHARMA UK LIMITED
End date in notice
30 Apr 2028
Value shown in notice
£1,009,500,000Whole award value; not assigned to one supplier
Official source

Published records by year

Supplier relationships by value counted

Contracts with end dates in the next 24 months

NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024